Serum levels of LDLc and/or CRP decreased in response to treatment with simvastatin 20 mg daily combined with ezetimibe 10 mg daily17, lovastatin 40 mg daily37, atorvastatin 10 mg daily38, and rosuvastatin 20 mg daily39, regardless of eGFR and history of diabetes or CVD. The gene discussed is CRP; the disease is diabetes mellitus.